180 Life Sciences Performance
| ATNFDelisted Stock | USD 2.58 0.18 7.50% |
The firm owns a Beta (Systematic Risk) of -6.24, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning 180 Life are expected to decrease by larger amounts. On the other hand, during market turmoil, 180 Life is expected to outperform it. 180 Life Sciences today owns a risk of 0.0%. Please confirm 180 Life Sciences value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to decide if 180 Life Sciences will be following its current price history.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days 180 Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, 180 Life is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
180 |
180 Life Relative Risk vs. Return Landscape
If you would invest 258.00 in 180 Life Sciences on November 27, 2025 and sell it today you would earn a total of 0.00 from holding 180 Life Sciences or generate 0.0% return on investment over 90 days. 180 Life Sciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than 180, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
180 Life Target Price Odds to finish over Current Price
The tendency of 180 Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.58 | 90 days | 2.58 | about 57.97 |
Based on a normal probability distribution, the odds of 180 Life to move above the current price in 90 days from now is about 57.97 (This 180 Life Sciences probability density function shows the probability of 180 Stock to fall within a particular range of prices over 90 days) .
180 Life Price Density |
| Price |
Predictive Modules for 180 Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as 180 Life Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.180 Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. 180 Life is not an exception. The market had few large corrections towards the 180 Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold 180 Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of 180 Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 4.79 | |
β | Beta against Dow Jones | -6.24 | |
σ | Overall volatility | 1.99 | |
Ir | Information ratio | 0.13 |
180 Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of 180 Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for 180 Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| 180 Life Sciences is now traded under the symbol ETHZ. Please update your portfolios or report it if you believe this is an error. Report It! | |
| 180 Life Sciences is not yet fully synchronised with the market data | |
| 180 Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| 180 Life Sciences currently holds 154.5 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. 180 Life Sciences has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about 180 Life's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (6.17 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| 180 Life Sciences currently holds about 1.63 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Latest headline from finance.yahoo.com: Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 12 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors |
180 Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of 180 Stock often depends not only on the future outlook of the current and potential 180 Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. 180 Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 915.4 K | |
| Cash And Short Term Investments | 4.6 M |
180 Life Fundamentals Growth
180 Stock prices reflect investors' perceptions of the future prospects and financial health of 180 Life, and 180 Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 180 Stock performance.
| Return On Equity | -3.71 | |||
| Return On Asset | -0.55 | |||
| Current Valuation | 403.32 M | |||
| Shares Outstanding | 153.03 M | |||
| Price To Earning | 0.63 X | |||
| Price To Book | 75.11 X | |||
| EBITDA | (6.32 M) | |||
| Cash And Equivalents | 1.63 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 154.5 K | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 0.89 X | |||
| Cash Flow From Operations | (1.48 M) | |||
| Earnings Per Share | (14.95) X | |||
| Total Asset | 12.76 M | |||
| Retained Earnings | (141.52 M) | |||
About 180 Life Performance
By analyzing 180 Life's fundamental ratios, stakeholders can gain valuable insights into 180 Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if 180 Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if 180 Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company was incorporated in 2016 and is headquartered in Palo Alto, California. 180 Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.Things to note about 180 Life Sciences performance evaluation
Checking the ongoing alerts about 180 Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for 180 Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| 180 Life Sciences is now traded under the symbol ETHZ. Please update your portfolios or report it if you believe this is an error. Report It! | |
| 180 Life Sciences is not yet fully synchronised with the market data | |
| 180 Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| 180 Life Sciences currently holds 154.5 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. 180 Life Sciences has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about 180 Life's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (6.17 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| 180 Life Sciences currently holds about 1.63 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
| Latest headline from finance.yahoo.com: Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 12 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors |
- Analyzing 180 Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 180 Life's stock is overvalued or undervalued compared to its peers.
- Examining 180 Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating 180 Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of 180 Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of 180 Life's stock. These opinions can provide insight into 180 Life's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in 180 Stock
If you are still planning to invest in 180 Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 180 Life's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |